Cas No.: 640756-12-3
PRODUCT INFORMATION
Description
C16Y is a synthetic oligopeptide designed as a selective antagonist for integrin receptors αvβ3 and α5β1. This cell-permeant compound is a tool for in vitro research, demonstrating potent inhibitory properties by disrupting integrin-mediated endothelial cell interactions at the plasma membrane. It is used to study the inhibition of biological processes related to neovascularization in cellular models.
Molecular Weight
1562.85
Purity
> 95%
Formula
C₇₈H₁₁₅N₁₇O₁₇
Product Type
Targeting Peptide
Sequence
Asp-Phe-Lys-Leu-Phe-Ala-Val-Tyr-Ile-Lys-Tyr-Arg
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- VSLRGDTRG Targeting Peptide (CAT#: OLY-1025-YS-32)
- Thrombin-cleavable Targeting Peptide (CAT#: OLY-1025-YS-34)
- rTAT Targeting Peptide (CAT#: OLY-1025-YS-20)
- NGR Targeting Peptide (CAT#: OLY-1025-YS-38)
- Tumor Targeted Pro-apoptotic Peptide (CAT#: OLY-1025-YS-48)
- GB-6 Targeting Peptide (CAT#: OLY-1025-YS-11)
- Cyclo(Arg-Gly-Asp-D-Tyr-ε-azido-Nle) Targeting Peptide (CAT#: OLY-1025-YS-62)
- CXCL8 (54-72) Targeting Peptide (CAT#: OLY-1025-YS-1)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.